The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20080579
de Yebenes et al.

Figure S1 Functional screening of an miRNA library.

Figure S2 Conservation of paralogous miR-181 sequences.

Figure S3 miR-181b does not affect cell proliferation or survival, or plasma cell differentiation.

Figure S4 miRNAs differentially expressed in activated B cells.

Figure S5 miR-181b quantification by real-time RT-PCR with miRNA reference panel.

Figure S6 miR-181b expression in transduced primary B cells.

Figure S7 AID mRNA levels are specifically reduced in B cells overexpressing miR-181b.

Figure S8 Putative miR-181b binding sites in human and mouse AID 3′UTRs.

Figure S9 Luciferase reporter assays of putative miR-181b binding sites in the mouse AID 3′UTR.

Figure S10 AID expression in LPS + IL-4–stimulated primary B cell cultures.

Tables S1-S3 (PDF)





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS